'Immunotherapy'

- Pediatric patients, less than 18 years old, with advanced 
  solid tumors and hematological malignancies                                       D419EC00001


- Patients aged from 28 days to less than 18 years of age with
  relapse/refractory B or T Acute Lymphoblatic Leukemia or AML           ACT15378